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1 Introduction
Alkaloids have been a tempting object of study for researchers
due to their multiple biological properties; some of which have
been known and used by mankind for medical purposes.1 A
particular and vast group of alkaloids are indole alkaloids,
which bears a structural moiety of indole,2 containing more
than 4100 known different compounds, it is one of the largest
classes of alkaloids.3ad de Ciencias Qúımicas, Universidad de
8 Salamanca, Spain. E-mail: ismarcos@
ones for his dedication as a teacher, for
ars.
Chemistry 2013Terpenoids are natural products present in nearly all the life
forms that have a great number of structural or functional
activities.4 These compounds are the biggest and most diverse
natural products group, with more than 65 000 known repre-
sentatives to date.5 From several years ago annual revisions of
newly isolated terpenoids: monoterpenes,6 sesquiterpenes,7
diterpenes,8 sesterterpenes9 terrestrial or marine origen10 and
triterpenes11 have been carried out.
Terpenyl indoles are hybrid natural products from indole
alkaloids and terpenoids,12 extensively studied due to their
challenging scaffold structures, complicated frameworks and
because they possess signicant physiological activities.13,14
Some of them have even been used in medicine since ancient
times, long before their structure was known.1b
Among terpenyl indoles, sesquiterpenyl indoles are a small
group of natural compounds, though very interesting due to
their molecular complexity and wide variety of biological
properties, such as antibacterial,15 anticancer or even anti-
HIV.16 The rst known example of a sesquiterpenyl indole
compound, is the natural product polyalthenol,17 isolated in
1976. Since then, several other sesquiterpenyl indoles have been
found, mainly from African medicinal plants, especially from
Greenwayodendron suaveolens (Polyalthia oliveri Engl. & Diels).
Most of these compounds have been isolated and fully charac-
terised in the decade of the eighties. However, their biological
properties remained unknown until two decades later, whenFig. 1


















































View Article Onlineantibiotic properties of suaveolindole18 and polyalthenol19
(Fig. 1) were reported in 2005 and 2010 respectively.
These results have revived interest in these compounds in
recent years, prompting research groups to further investigation
of the biological properties, synthesis, biogenesis and sourcesIsidro Sánchez Marcos received
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1510 | Nat. Prod. Rep., 2013, 30, 1509–1526of isolation of these compounds, so in recent years, sesqui-
terpenyl indoles have been found not only in plants, but also as
secondary metabolites of fungi and bacteria,15,20 especially from
endophytes16 associated with mangroves. In fact, nearly all of
the sesquiterpenyl indoles isolated from mangrove endophytes
show antibiotic properties.202 Classification
Until now there has been no classication of the known
sesquiterpenyl indoles. Due to the interesting biological prop-
erties, the novelty and structural diversity that some of them
show, we considered it to be very interesting to establish a
classication of these compounds.Dr Pilar Basabe Barcala is Full
Professor of Organic Chemistry at
the University of Salamanca and
obtained her PhD at the same
University in 1973 under the
supervision of Professors J. de
Pascual Teresa and J. G. Urones.
She has worked in the eld of
natural product chemistry and
has over 160 publications in the
area.
David Diez received his BSc in
Chemistry at the University of
Salamanca in 1982. In 1986 he
completed his PhD at the same
University under the supervision
of Professors J. G. Urones and
I. S. Marcos. Then, he spent a
postdoctoral stay (1988–1990,
British Council Fellowship) with
Professor Steven V. Ley at Impe-
rial College of Science, Tech-
nology and Medicine (London)
DIC 1991. He became Associate
Professor in 1991 at the University of Salamanca and Full Professor
in 2008 at the same University. He is co-author of more than 150
papers and he acts as referee for international scientic journals.
His current research interests are focused in the transformation of
natural products into biologically active compounds, the chemistry
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View Article OnlineHerein we show a review of the 43 natural sesquiterpenyl
indoles isolated and characterised up to date. The following
collection comprises a list of structures, each of which is
accompanied by its trivial name and is numbered, along with
tables that include the source of isolation, biological activities
and the literature. We have classied them attending to their
sesquiterpene skeleton, (Fig. 2) and the way this moiety joins to
the indole residue.
In this manner the published structures can be classied
into three main groups: farnesyl, drimanyl and aureanyl21
indoles. All the sesquiterpenyl indoles presented in the reviewTable 1 Farnesyl indoles
Farnesyl indoles Natura
3-Farnesylindole, 1 Uvaria
(80,90-Dihydroxy)-3-farnesylindole, 2 U. pan
(60,70-Dihydro-80,90-dihydroxy)-3-farnesylindole, 3 U. pan
Fig. 3
This journal is ª The Royal Society of Chemistry 2013that have the terpene part cyclic are drimane or rearranged
drimane skeleton, aureane, (Fig. 2) skeleton that arises from 1,2
rearrangements of the drimane skeleton. We proposed the
name aureane for the rearranged skeleton considering aureol as
one of the rst sesquiterpenyl hybrid compound isolated.22
2.1 Farnesyl indoles
The farnesyl indole group (Fig. 3) is constituted only by three
compounds 1, 2, 3 isolated from Uvaria pandensis, a plant native
of Tanzania, of the Annonaceae family. (Table 1)
2.2 Drimanyl indoles
Drimanyl indoles form the most numerous group of sesqui-
terpenyl indoles. (Table 2) They can be classied as: drimanyl
indole simple, pentacyclic drimanyl indoles and diketopiper-
azinic drimanyl indoles.
2.2.1 Simple drimanyl indole. Only one is known, the
indosespene 420 (Fig. 4).
2.2.2 Pentacyclic drimanyl indoles. They are the most
numerous group. Their structures can be distinguished by the
connection between the drimane and indole fragments. In this
manner, several subdivisions can be established:
-driman[11,8-b]indoles: 5 and 6 (Fig. 5)
-driman[8,11-a]indoles: 7, 8, 9, 10 and 11 (Fig. 6)
-driman[9,12-b]indoles: 12, 13, 14, 15 and 16 (Fig. 7)
-driman[12,9-b]indoles: 17 (Fig. 8)
-driman[12,11-b]indoles: 18, 19, 20, 21, 22, 23, 24, 25 and
26 (Fig. 9).
Recently, several dimer compounds of the driman[12,11-b]
indoles, dixiamycines A 25 and B 2615 (Fig. 9), have been iso-
lated and characterised. These are the only natural
atropoisomers known to possess axial chirality due to a N–N
bond, and show more potent antitumoural and antibacterial
activities than the corresponding monomers. Compounds
belonging to this group can be considered carbazole derivative
alkaloids, a very important group of anticancer agents, top-
oisomerase I/II, telomerase and quinase inhibitors.23 Due to
these very interesting biological properties, many synthetic
strategies have been developed24 for the synthesis of unnatural
carbazoles and derivatives.
It is necessary to point out that the group of driman[8,11-a]
indoles has been the object of careful consideration. The rst
compounds of this group, named polyavolensin, poly-
avolensinol and poliavolensinone,25 were isolated in 1981
from the bark of Greenwayodendron suaveolens (previously
known as Polyalthia suaveolens Engl. & Diels) collected in
Nigeria, and their structure and stereochemistry were pub-
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Table 2 Drimanyl indoles
Drimanyl indoles Natural source Activity References
3-Drimanyl indole
Indosespene, 4 Streptomyces sp. HKI0595 Antimicrobiane 20
Driman[11, 8-b]indoles
Polyveoline, 5 Greenwayodendron suaveolens Antiparasitic 32, 33
N-Acetylpolyveoline, 6 G. suaveolens Antiparasitic 33
Driman[8,11-a]indoles
Greenwayodendrin-3-one, 7 Greenwayodendron suaveolens Antiparasitic 25, 26, 27 and 33
3b-Acetoxy-greenwayodendrine, 8 G. suaveolens Antiparasitic 25, 26, 27, 29 and 33
3a-Hydroxy-greenwayodendrine, 9 G. suaveolens 27
3b-Hydroxy-greenwayodendrine, 10 G. suaveolens 27
Polysin, 11 G. suaveolens Antiparasitic 33
Driman[9,12-b]indoles
Lecanindole A, 12 Verticillium lecanii 34
Lecanindole B, 13 V. lecanii 34
Lecanindole C, 14 V. lecanii 34
Lecanindole D, 15 V. lecanii Progesterone receptor agonist 34
Sespendole, 16 Pseudobotrytis terrestris FKA-25 Cholesterol acetyl transferase and
cholesteryl ester synthesis inhibitor
35, 36 and 37
Driman[12,9-b]indoles
Polyavolinamide, 17 Greenwayodendron suaveolens 38
Driman[12,11-b]indoles
Xiamycin A, 18 Streptomyces sp. GT2002/1503,
sp. HKI0595, sp. SCSIO 02999
Anti-HIV, antitumoural,
antiviric, antimicrobial
15, 16, 20 and 39
Xiamycin A methyl ester, 19 Streptomyces sp. GT2002/1503 Antitumoural 16
Xiamycin B, 20 Streptomyces sp. HKI0595 20
Chloroxiamycin A, 21 Streptomyces sp. SCSIO 02999 Antitumoural, antibacterial 15
Oridamycin A, 22 Streptomyces sp. KS84 Antibiotic 40
Oridamycin B, 23 Streptomyces sp. K 584 Antibiotic 40
Oxiamycin, 24 Streptomyces sp. SCSIO 02999 Antitumoural, antibacterial 15, 39
Dixiamycin A, 25 Streptomyces sp. SCSIO 02999 Antitumoural, antibacterial 15
Dixiamycin B, 26 Streptomyces sp. SCSIO 02999 Antitumoural, antibacterial 15
Diketopiperazinic drimanyl indoles
Drimentine A, 27 Actyniomycetes MST-8561 Antibiotic, antifungic, anticancer 41
Drimentine B, 28 Actyniomycetes MST-8561 Antibiotic, antifungic, anticancer 41
Drimentine C, 29 Actyniomycetes MST-8561 Antibiotic, antifungic, anticancer 41
Drimentine F, 30 Streptomyces sp. CHQ-64 42
Drimentine G, 31 Streptomyces sp. CHQ-64 Anticancer 42
Drimentine H, 32 Streptomyces sp. CHQ-64 28
Drimentine D, 33 Actyniomycetes MST-8561 Antibiotic, antifungic, anticancer 41
Drimentine E, 34 Actyniomycetes MST-8561 Antibiotic, antifungic, anticancer 41
Indotertine A, 35 Streptomyces sp. CHQ-64 42


















































View Article Onlineresearch group published a revised structure of polyavolensin,
determined by X-Ray crystallography. In the meantime,
another research group reported the isolation of four new
sesquiterpenyl indoles from the bark of a Congolese Green-
wayodendron suaveolens (Engl. & Diels) Verdc. (Annonaceae)
that were named greenwayodendrin-3-one 7, 3b-acetoxy-
greenwayodendrine 8, 3a-hydroxy-greenwayodendrine 9, and
3b-hydroxy-greenwayodendrine 10,27 whose structure and
stereochemistry were determined by X-ray crystallography.
Aer comparing the structures of these compounds we
have found out that polyavolensin and 3b-acetoxy-green-
wayodendrine 8 are actually the same compound, and this
happens as well with polyavolensinol and 3b-hydroxy-green-
wayodendrine 10, and with polyavolensinone and green-
wayodendrin-3-one 7. In this work we have decided to keep the
names given by Waterman's group,27 as they suit better the
modern name of the parental plant.1512 | Nat. Prod. Rep., 2013, 30, 1509–15262.2.3 Diketopiperazinic drimanyl indoles. They are a group
characterised by the presence of a complete tryptophan unit
bonded to a second amino acid, such as valine, leucine or proline,
forming a diketopiperazine unit, 27–36 (Fig. 10). Very recently
indotertine B 36 has been isolated, with two rotamers charac-
terised 36a and 36b about the N–C (O) bond in a 2 : 1 ratio.282.3 Aureanyl indoles
Aureanyl indoles (Fig. 11) can be divided into three different
groups: 3-aureanyl indoles, 2-aureanyl indole and pentacyclic
aureanyl indole. (Table 3)
2.3.1 3-Aureanyl indoles (37–41). This group includes the
rst sesquiterpenyl indole known polyalthenol 37,17,19 its isomer
isopolyalthenol 3829 and the ring A seco-derivatives of the
sesquiterpene fragment, suaveolindole 39 and derivatives 40























































View Article Online2.3.2 2-Aureanyl indole. Neopolyalthenol 42, is the only one
known.29 (Fig. 11)
2.3.3 Pentacyclic aureanyl indole. Recently this has been
isolated and characterized as the only one pentacyclic aureanyl
indole known, until now, that show a new carbon skeleton
corresponding to aurean[1,11-b]indole and known as pentacy-
clindole 43.19(Fig. 11)3 Biosynthesis
We now present a biogenetic proposal for all the sesquiterpenyl
indoles previously mentioned. Basically, all sesquiterpenyl
indoles have the same rst biogenetic step that consists of the
condensation of an indole moiety and a terpene moiety that,
according to isotopic marking and feeding experiments, comes
from the mevalonate or non-mevalonate pathway44,45 to form the
terpenyl indole precursor skeleton. Thus, a general biosynthetic



















































View Article OnlineWe take as a basis of our proposal the interesting study45 that
Oikawa and co-workers have recently published, in which the
biosynthetic route that leads to indole diterpenes is thoroughly
explained on a genetic basis, and exemplied with the
description of the biogenesis of the natural product paxilline, a
diterpene indole tremorgenic mycotoxin. In the same mannerFig. 9
1514 | Nat. Prod. Rep., 2013, 30, 1509–1526Zhang and co-workers recently described the identication and
characterisation of eighteen genes involved in the biosynthesis
of xiamycin A 18 and oxiamycin 24.39
Herein, the biogenesis of sesquiterpenyl indoles is analo-
gous to the biogenetic pathway of paxilline and xiamycin A 18,
in which several types of gene clusters are involved: a prenyl-
transferase attaches the terpenyl fragment, farnesyl pyrophos-
phate (FPP), to indole-3-glycerol phosphate,46 (Scheme 1) and
then a sequence of oxidations and cyclisations promoted by
oxygenases and transformant enzymes lead to a wide variety of
sesquiterpene indole scaffolds. These cyclisations can occur
with different regiochemistries.47 The structural diversity and
stereochemistry of the indole-terpenoid scaffolds resulting
would depend on the conformation that the terpene unit adopts
before cyclisation.48 Isotopic marking experiments on diter-
penyl indoles, demonstrated that indole-3-glycerol phosphate is
the preferred substrate for the enzyme, and not the tryptophan
one.46 For the biosynthesis of the different sesquiterpenyl
indoles three pathways A, B and C can be distinguished



















































View Article OnlineIn pathway A a prenyl transferase inserts a farnesyl diphos-
phate unit at the C3 position of an indole 3-glycerol phosphate
giving an intermediate. Elimination of glyceraldehyde 3-phos-
phate takes place, leading to a 3-farnesyl indole I that can undergo
oxidation and cyclisation to afford different sesquiterpenyl
indoles, such as 3-drimanyl indole (indosespene 4), driman[12,11-This journal is ª The Royal Society of Chemistry 2013b]indoles 18–26 and driman[9,12-b]indoles 12–16, 3-aureanyl
indoles 37–41 and aurean[1,11-b]indole (pentacyclindole 43). In
pathway B a different prenyl transferase directly attaches the FPP
fragment to the C2 position;49,50 then a hydride shi fromC2 to C3
and elimination of glyceraldehyde 3-phosphate affords the 2-far-
nesyl indole derivative II, an oxidation and cyclisation sequenceNat. Prod. Rep., 2013, 30, 1509–1526 | 1515
Fig. 11
Table 3 Aureanyl indoles
Aureanyl indoles Natural source Activity References
3-Aureanyl indoles
Polyalthenol, 37 Polyalthia oliveri Engl. & Diels Antibiotic 17, 19 and 43
Greenwayodendron oliveri Verdc.
Polyalthia suaveolens
Isopolyalthenol, 38 Greenwayodendron suaveolens 29
Suaveolindole, 39 G.suaveolens Antibiotic 18, 19
Suaveolindole methyl ester, 40 G.suaveolens 19
41 G.suaveolens Antibiotic 19
2-Aureanyl indole
Neopolyalthenol, 42 G. suaveolens 29
Aurean[1,11-b]indole


















































View Article Onlineaffords different sesquiterpenyl indoles: 2-aureanyl indole (neo-
polyalthenol 42), driman[11,8-b]indoles 5–6, driman[8,11-a]
indoles 7–11 and driman[12,9-b]indole (polyavolinamide 17). In
pathway C an extra amino acid unit is required. Indole 3-glycerol
phosphate needs to be converted to tryptophan, then addition of a1516 | Nat. Prod. Rep., 2013, 30, 1509–1526second unit of an amino acid (proline, valine or leucine) affords
the formation of a diketopiperazinic ring. Prenylation at C3 takes
place, yielding the diketopiperazinic drimanyl indoles III14 that
can undergo oxidation and cyclisation to afford different sesqui-



















































View Article OnlineStarting from the main precursors I, II and III, the three
biosynthetic pathways will now be commented on in more
detail. To avoid numbering confusion, we have kept the dri-
manyl and aureanyl skeleton numbering as has been already
used in section 2.
It is noticeable that, except for the diketopiperazinic dri-
manyl indoles 27–36 and the 3-farnesyl indoles 1–3, all the rest
present an oxygenated function in C-3 of the sesquiterpenic
moiety (C-19 sesquiterpenyl indole). On this basis, we have
assumed that biosynthetic pathways A and B, as occurs for
paxilline, suffer a series of epoxidation/cyclisation steps.3.1 Biosynthesis of 3-farnesyl indole derivatives (Pathway A)
Scheme 2 shows the biosynthetic route that leads to 3-farnesyl
indole I related compounds. Once the acyclic terpenyl precursor
I is formed, it suffers a selective epoxidation of the terminal
double bond45 to give a terpenyl u-epoxide, that can adopt two
different conformations 44 or 45.
A Markovnikov cyclisation of the terpenyl u-epoxide when
adopting a chair-chair conformation as represented in inter-
mediate 44, leads to a decalin intermediate 46. This compoundThis journal is ª The Royal Society of Chemistry 2013evolves into exo-olen 46a which would lead to 3-drimanyl
indole and by oxidation to indosespene 4, or by cyclisation with
the indole unit to afford driman[12,11-b]indoles, and further
transformations yield the natural products 18–26.
It is also possible that the linear u-epoxide of 3-farnesy-
lindole adopts a chair-boat conformation, as represented by 45.
A Markovnikov cyclisation may afford the decalin intermediate
47 that, aer hydrogen and methyl migration, leads to 3-aur-
eanyl indoles 37–41. Cyclisation and oxidation of the 3-aureanyl
indole give the aurean[1,11-b]indole (pentacyclindole 43). To
support this, it is worth mentioning that acid catalyzed cycli-
sation of 3-but-3-enyl indole derivatives51 have been reported
with good yield, affording pentacyclic indole derivatives.52
Finally, an anti-Markovnikov cyclisation46 of the chair-chair
u-epoxifarnesyl indole 44, gives intermediate 48, ring expansion
leads to 49, cyclisation with the indole moiety yields 50 and
ulterior oxidation produces the driman[9,12-b]indoles 12–16.3.2 Biosynthesis of 2-farnesyl indole derivatives (Pathway B)
Analogously to pathway A, 2-farnesyl indole II is converted to its



















































View Article Onlineu-epoxide adopts a chair-chair conformation as represented in
51, a Markovnikov cyclisation leads to a drimanyl indole inter-
mediate 53 that affords driman[8,11-a]indoles 7–10, it being the
N–H bond that is involved in the cyclisation.
When the u-epoxide of 2-farnesyl indole II adopts a chair-
boat conformation, 52, Markovnikov cyclisation gives interme-
diate 54 that can evolve either hydrogen and undergo methyl
migration to 2-aurenyl indole (neopolyalthenol 42), by cyclisa-
tion to the driman[8,11-a]indole (polysin 11) if the N–H bond of
the indole participates in the cyclisation, or if C3 is the one
involved in the cyclisation to driman[11,8-b]indoles 5–6.
Finally, the anti-Markovnikov cyclisation of 51 leads to
intermediate 55, that aer ring expansion produces the decalin
56, and further cyclisation at C3, reduction and ulterior acyla-
tion affords the driman[12,9-b]indole, polyavolinamide 17.1518 | Nat. Prod. Rep., 2013, 30, 1509–15263.3 Biosynthesis of diketopiperazinic drimanyl indoles
(Pathway C)
In Scheme 4 the biosynthesis of drimentines A–H, 27–34, is
shown and indotertines A 35, B 36 (formyl derivative of 35) from
their common precursor III. The key intermediate for these
natural products is 59, that can be formed from intermediates
57 or 58, by cyclisation of the diketopiperazine with the indole
moiety before or aer the Markovnikov cyclisation of the ter-
penic moiety of III. Deprotonation of 59 would lead directly to
drimentines 27–32 and cyclisation with the nitrogen of the
indole will give to drimentines 33–34. During the revision of this
work the synthesis of drimentines A 27, F 30, G 31 and indo-
tertine A 35 has appeared in the literature.62 In that work the



















































View Article Onlinemedia of drimentine F 30. In that manner the hypothesis that
indotertines proceed biogenetically by acid catalysed cyclisation
through the iminium ion 57a is corroborated. Nevertheless, it
can not be ignored that indotertines 35–36 could be formed
directly from 57, by deprotonation followed by acidic cyclisation
in the same way as it has been already described in pathway A,
Scheme 2, for driman[12,11-b]indoles (18–26), with no partici-
pation of the pirroloindole intermediate 59.4 Syntheses and synthetic approximations
Until the moment of sending this manuscript, only two total
syntheses of sesquiterpenyl indoles have been published
(Fig. 12): 3-farnesyl indole 153 and suaveolindole 39.54 DuringThis journal is ª The Royal Society of Chemistry 2013the manuscript revision two new contributions have appeared
in the literature, one describing the synthesis of lecanindole D
15,61 another reporting the synthesis of drimentines A 27, F 30,
G 31 and indotertine A 35.62 Several syntheses of analogues, of
the natural sesquiterpenyl indoles, polyalthenol 37 and poly-
veoline 5, that is, 12-epi-ent-polyalthenol 60,55 12-epi-ent-penta-
cyclindole 6152 and polyveoline analogue 62,56 have also been
reported, as well as a couple of synthetic approaches towards a
non-natural drimanyl indole 6357 and sespendole 16.584.1 Total synthesis
The rst synthesis was communicated in 1985,59 two years



















































View Article Onlineproduct itself and it is the synthesis of the more simple
sesquiterpenyl indole, 3-farnesyl indole 1. This rst total
synthesis (Scheme 5) consists on the direct alkylation of indo-
lylmagnesium iodide with E,E-farnesyl bromide.
Later on, in 200253 another synthesis of 3-farnesyl indole 1
(Scheme 6) was published with better global yield. In this
manuscript is described the synthesis of a series of alkyl
indoles, among them 3-farnesyl indole 1, by direct alkylation
of indoles in position 3 with alkyl halides and zinc triate,
in the presence of tetrabutylamonium iodide and N,N-
diisopropylethylamine.
In 2007 Danishefsky and Velthuisen published the rst total
synthesis of suaveolindole 39.54 In this work the key step is an
Ireland–Claisen rearrangement to obtain the terpenic moiety of
suaveolindole 39 (Scheme 7).
Addition of an appropriate magnesium derivative to
6-methyl-2-cyclohexen-1-one 64, followed by oxidation and
ulterior ozonolysis of the terminal double bond lead to the
intermediate 65 (Scheme 7). Treatment of this compound with
2-iodoaniline and Pd(OAc)2 gave the indole fragment. Protec-
tion of the indole unit as its tosyl derivative, 1,4 addition of1520 | Nat. Prod. Rep., 2013, 30, 1509–1526methyl lithium and trapping of the enolate formed as its triate,
gave intermediate 66. Carbonylation of 66 takes place in CO
atmosphere in the presence of Pd0 to give, aer treatment
with MeLi and acetylation, the required substrate 67. This
compound was submitted to an Ireland–Claisen rearrangement
by treatment of the allylic acetate 67with LiHMDS and TMSCl to
obtain 68. An Arndt–Eistert homologation and deprotection of
the indole unit gave the natural product (+)-suaveolindole 39.
Recently Kuwahara and co-workers, based on their experi-
ence in the total synthesis of paspalinine,63 adopted 83 as the
key intermediate for the synthesis of racemic lecanindole D
()-15.61 (Scheme 8) This known compound had been previously
prepared in 6 steps from the Wieland–Miescher ketone.63
Aer hydroxyl group protection of 83, and deprotection of
the carbonyl one, the gem-dimethyl is introduced to give 84, that
by reduction and epoxidation led to 85. (Scheme 8). The epoxide
reduction permitted the tertiary hydroxyl group followed by
protection of the secondary alcohol with TBSOTf, hydro-
genolysis for removal of the benzyl group and subsequent
oxidation lead to 86. Treatment of the cyclopropyl ketone





















































View Article Onlineabout reductive cleavage of the cyclopropane ring to generate an
enolate intermediate, which was then trapped in situ with
Comins' reagent to afford enol triate 87. Stille coupling of 87
with an o-stannylated aniline derivative 88 under Corey's
conditions gave 89. The o-alkenyl aniline derivative 89 was then
treated with Pd(OCOCF3)2 in DMSO to furnish an indole ring
containing pentacyclic product. Finally, deprotection of the TBS
group and removal of the Boc group completed the synthesis of
lecanindole D ()-15. The 1H and 13C NMR spectra of ()-15
were identical with those of natural lecanindole D.
The synthesis of sesquiterpenyl indoles, indotertine A 35,
drimentines A, F, and G 27, 30 and 3162 represent a superb
contribution of Li and co-workers to this eld (Scheme 9). The
key step for the synthesis of drimentines A, F, and G 27, 30This journal is ª The Royal Society of Chemistry 2013and 31, is an intermolecular radical conjugate addition of
intermediates 91 and 93 which are readily available from
(+)-sclareolide and bis(Boc-L-tryptophan)methyl ester 92
respectively. The synthesis of indotertine A 35 is carried out
based in a biosynthetic hypothesis from drimentine F 30.
Aer several attempts using different conditions the
radical conjugated addition of 91 and 93 was carried out in
the presence of [Ir(ppy)2(dtbbpy)]PF6, blue LED, Et3N,
obtaining 94 in good yield, (ppy¼ 2-phenylpyridine; dtbbpy¼
4,40-di-tert-buthyl-2,20-bipyridine) (Scheme 9). Boc depro-




















































View Article OnlineL-leucine derivatives 95a, 95b and 95c led to amides 96a–c that
by reaction with triuoroacetic acid followed by basication
with NH3$H2O furnished diketopiperazines 97a–c. Direct
methylenation was not possible in many conditions, so in
order to achieve the synthesis of the natural products dri-
mentine G 31, A 27, and F 30 it was necessary to use the
Grignard reaction and dehydration of the tertiary alcohol
formed. Treatment of drimentine F 30 with Bi(OTf)3/KPF6
smoothly rendered indotertine A 35.4.2 Synthetic approaches
Recently Marcos and co-workers reported the synthesis and
antitumoural activity of 12-epi-ent-polyalthenol 6055 a poly-
althenol epimer and 12-epi-ent-pentacyclindole 6152 a pentacy-
clindole epimer, using ent-halimic acid 6960 as starting material
(Scheme 10). In this synthesis we can distinguish four main
steps: (1) preparation of the trinorditerpenyl derivative 70; (2)
oxidation of the C-3 position of the terpenyl fragment giving 71;
(3) incorporation of the indole moiety that led to 60 by Fischer
indolization and (4) cyclisation and oxidation to the required
indole 61. This route is summarized in Scheme 10.1522 | Nat. Prod. Rep., 2013, 30, 1509–1526In 1987, Mirand and co-workers56 reported a synthesis of 62
an analogue (Scheme 11) of the natural product polyveoline 5,
by cyclisation of a 30-u-epoxide-2-farnesyl indole.
The rst step of this synthesis involves the formation of an
N-protected-2-farnesylindole 73, which can be accomplished by
treatment of the corresponding N-protected indole 72 with
n-BuLi, followed by treatment with E,E-farnesyl bromide
(Scheme 11). Formation of the 30-u-epoxide 74 was achieved by
reaction with NBS and then treatment of the resultant bromo-
hydrine under basic conditions. Cyclisation of the sesquiter-





















































View Article Onlineacid. Finally, N-deprotection and reduction of the indole affor-
ded compound 62.
A non-natural indole sesquiterpene neopolyalthenol
analogue 63 has been synthesized as well. This compound canThis journal is ª The Royal Society of Chemistry 2013be considered as a common intermediate57 (Scheme 12) in the
biosynthesis of neopolyalthenol 42 and greenwayodendrin-like
natural indole sesquiterpenes, using sclareol 76 as a starting
material.
Sclareol 76 was rst oxidized with ruthenium chloride and
sodium periodate to give 77 (Scheme 12). Treatment of
compound 77 with thionyl chloride and the crude product with



















































View Article Online79. Finally, dehydration was accomplished by treating 79 with
SnCl4, that led to 63. Further rearrangements and oxidations of
the sesquiterpene moiety of compound 63 could lead to neo-
polyalthenol 42 and the greenwayodendrin compounds.Scheme 13
1524 | Nat. Prod. Rep., 2013, 30, 1509–1526More recently there has been an attempt at synthesizing
()-sespendole 16.58 The pentacyclic system synthesis is
designed using 80 as an intermediate. Although the challenge of
assembling aniline and sesquiterpene fragments 8158a and 8258b
to give intermediate 80 has not been possible until date,
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V. Bénéteau and J.-Y. Mérour, Tetrahedron Lett., 2005, 46,
6071–6074.
24 (a) E. Duval and G. D. Cuny, Tetrahedron Lett., 2004, 45,
5411–5413; (b) R. Pathak, J. M. Nhalpo, S. Govender,
J. P. Michael, W. A. L. van Otterlo and C. B. de Koning,
Tetrahedron, 2006, 62, 2820–2830; (c) H.-J. Knölker and
K. R. Reddy, Chem. Rev., 2002, 102, 4303–4428.
25 D. A. Okorie, Tetrahedron, 1980, 36, 2005–2008.
26 C. P. Falshaw, T. J. King and D. A. Okorie, Tetrahedron, 1982,
38, 2311–2313.
27 C. M. Hasan, T. M. Healey, P. G. Waterman and
C. H. Schwalbe, J. Chem. Soc., Perkin Trans. 1, 1982, 2807–
2812.
28 Q. Che, T. Zhu, R. A. Keyzers, X. Liu, J. Li, Q. Gu and D. Li,
J. Nat. Prod., 2013, 76, 759–763.
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